| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |